Efficient Degradation of Recalcitrant Pharmaceuticals in Greywater Using Treatment of MBR and Immobilized TiO<sub>2</sub> Porous Layers
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388955%3A_____%2F24%3A00602787" target="_blank" >RIV/61388955:_____/24:00602787 - isvavai.cz</a>
Výsledek na webu
<a href="https://hdl.handle.net/11104/0360098" target="_blank" >https://hdl.handle.net/11104/0360098</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1021/acsestwater.4c00618" target="_blank" >10.1021/acsestwater.4c00618</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Efficient Degradation of Recalcitrant Pharmaceuticals in Greywater Using Treatment of MBR and Immobilized TiO<sub>2</sub> Porous Layers
Popis výsledku v původním jazyce
Traditional wastewater treatment often fails to remove pharmaceuticals, necessitating advanced solutions, such as TiO2 photocatalysis, for post-treatment. However, conventionally applied powder TiO2 can be cumbersome to separate from treated water. To solve this issue, this study immobilized three TiO2 photocatalysts (Anatase 16, Anatase 5, and P25) into porous layers and evaluated their efficacy for the degradation of three pharmaceuticals (naproxen, NPX - sulfamethoxazole, SMX - metformin, MTF) in standard solutions and greywater pretreated in a membrane bioreactor (MBR). In standard solutions, photocatalysis tests revealed a high degradation efficacy (NPX 100%, SMX 76-95%, MTF 57-75%) and challenged the belief that OH center dot is the predominant reactive oxygen species (ROS). The primary ROS were 1O2 for NPX and OH center dot for SMX and MTF. The raw greywater (NPX, SMX, MTF 0.5 mg<middle dot>L-1) treatment in MBR removed only 17-22% of the pharmaceuticals, highlighting the need for post-treatment. Using this pretreated greywater, P25 layers excelled for NPX (78 +/- 5%) and SMX (73 +/- 4%) but were less effective for MTF (40 +/- 16%) compared to Anatase 16 (60 +/- 10%). Moreover, the effluent toxicity (Aliivibrio fischeri) was reduced, and the degradation products were identified. Overall, TiO2 layers are a high-potential method for removing pharmaceuticals from MBR-treated greywater.
Název v anglickém jazyce
Efficient Degradation of Recalcitrant Pharmaceuticals in Greywater Using Treatment of MBR and Immobilized TiO<sub>2</sub> Porous Layers
Popis výsledku anglicky
Traditional wastewater treatment often fails to remove pharmaceuticals, necessitating advanced solutions, such as TiO2 photocatalysis, for post-treatment. However, conventionally applied powder TiO2 can be cumbersome to separate from treated water. To solve this issue, this study immobilized three TiO2 photocatalysts (Anatase 16, Anatase 5, and P25) into porous layers and evaluated their efficacy for the degradation of three pharmaceuticals (naproxen, NPX - sulfamethoxazole, SMX - metformin, MTF) in standard solutions and greywater pretreated in a membrane bioreactor (MBR). In standard solutions, photocatalysis tests revealed a high degradation efficacy (NPX 100%, SMX 76-95%, MTF 57-75%) and challenged the belief that OH center dot is the predominant reactive oxygen species (ROS). The primary ROS were 1O2 for NPX and OH center dot for SMX and MTF. The raw greywater (NPX, SMX, MTF 0.5 mg<middle dot>L-1) treatment in MBR removed only 17-22% of the pharmaceuticals, highlighting the need for post-treatment. Using this pretreated greywater, P25 layers excelled for NPX (78 +/- 5%) and SMX (73 +/- 4%) but were less effective for MTF (40 +/- 16%) compared to Anatase 16 (60 +/- 10%). Moreover, the effluent toxicity (Aliivibrio fischeri) was reduced, and the degradation products were identified. Overall, TiO2 layers are a high-potential method for removing pharmaceuticals from MBR-treated greywater.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10403 - Physical chemistry
Návaznosti výsledku
Projekt
Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2024
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
ACS ES&T Water
ISSN
2690-0637
e-ISSN
2690-0637
Svazek periodika
4
Číslo periodika v rámci svazku
12
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
11
Strana od-do
5587-5597
Kód UT WoS článku
001367655300001
EID výsledku v databázi Scopus
2-s2.0-85210768208